The US FDA has accepted AstraZeneca’s standalone flu vaccine for review

AstraZeneca said Tuesday that the U.S. Food and Drug Administration (FDA) has accepted for review the company’s application for approval for patients or caregivers to administer its nasal influenza vaccine.

Share This Post:

POPULAR POSTS
FOLLOW US
Like Us On Facebook
Follow Us On Twitter
Subscribe To Our Channel
TikTok
LIVE STREAM